Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure (CACT-IHF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by State Administration of Traditional Chinese Medicine of the People's Republic of China
Sponsor:
Information provided by (Responsible Party):
Jingyuan Mao, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier:
NCT01555320
First received: February 29, 2012
Last updated: March 19, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
No publications provided by State Administration of Traditional Chinese Medicine of the People's Republic of China

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):